Blog / Archives
AACC Brief #2 Issues Arising-Reimbursement and Lab Developed Tests
The 2013 AACC (American Association for Clinical Chemistry) Meeting was attended by 650 exhibitors and over 17,000 professionals all looking to connect in the In Vitro Diagnostics (IVD) industry....
Profit Taking in Biotech Triggered by Regeneron (REGN) Miss Update 5p
Weakness in NASDAQ and Earnings Miss Gives an Excuse To Sell The Blistering 14% July Run in Biotech Comes to an End It was inevitable that something would cause biopharmaceutical stocks to falter....
AACC 2013 Update #1 Company Briefs: NSPH, NSTG, VIVO
Interesting Companies and Updates from American Association of Clinical Chemistry (AACC) Trade Show Update #1 We spent two busy days attending this diagnostics and tools meeting and there was a...
Rayno Life Science Stocks: New Highs and Riding Momentum of NASDAQ- ALR, ARRY, CBST, SGEN etc.
Biotech ETF (IBB) Hits New High of $200-Mid Caps Get Turbo Boost Positive Economic Data Helps The life science sector roared ahead again today helped by a 1% move in NASDAQ now at YTD highs up 21%....
AACC in Houston This Week
If anyone has questions or suggestions for new companies or news to follow, send me an Email. Rod Raynovich
Focus on Clinical Diagnostics: AACC Next Week- ABAX, ALR, CPHD, QDEL,TMO
Diagnostics and Tools Stocks Are At New Highs We will be attending the American Association of Clinical Chemistry Meeting in Houston next week. Our focus stocks are summarized below and as you can...
Rayno DX and Tools: Some Big Winners Today ILMN,RGDX
Movers in Rayno Diagnostics and Tools Stocks On a lackluster day in the market two of our picks were up big,two others exceeded one year highs. Illumina (ILMN $81) was up 10% on earnings to an all...
The Biotech Bull Market: Just Hold the Course and Let Profits Ride… Update 1
Rayno Life Science: Mid-Day Movers - IBB down 0.9% UP Diagnostics and Tools: Cepheid (CPHD) up 2.55%.Hologic (HOLX) up 3.7%, Response Genetics (RGDX) up 3.2% Biopharmaceuticals: Array (ARRY) up...
Watch For Sell-Off Tomorrow-Caution Urged Update 1 7/19
7/19 11:45a EDT Update -Correction Limited to Techs, Biotechs Surge Tech correction continues with XLK down 1.5% but more money finding its way into biotech "bubblet" with IBB ($195) up...
Life Science Mutual Funds and ETFs: Up 30-46% 2013 YTD
"1,2,3 Click" -Investing in Life Sciences The bull market in biotech is big and broad enough to make everyone look good and one fund or ETF can "deliver alpha" without exhaustive research or stock...